Medac GmbH Develops Pharmacovigilance Technology For Safety Monitoring of its Drugs with ArisGlobal Solutions

LifeSphere Safety has been selected by medac, a German-based pharmaceutical manufacturer specializing in oncology and hematology, urology, and autoimmune diseases, to modernize its drug safety processes, according to ArisGlobal, a market leader in global drug development technology solutions. Precise, patient- and population-specific analysis is critical for reducing treatment risks for patients and achieving the best possible treatment outcome.

"ArisGlobal's Safety solutions will significantly advance the automatization of adverse event management and intelligent safety analysis and will support us in making pharmacovigilance processes even smarter and more efficient," said Doctor Nadine Schreiber, Head of Global Pharmacovigilance of medac. LifeSphere Safety's main solution for automated case processing, LifeSphere MultiVigilance, as well as Reporting and Analytics and EV Triage, will be launched by medac.

"LifeSphere has been developed with organizations like medac in mind; to meet global compliance, provide next-level safety insights, and operate with greater efficiency," shares Aman Wasan, Chief Commercial Officer, ArisGlobal. "We are pleased that medac has entrusted LifeSphere products to continue their advancement of therapeutic development processes. We are confident that medac will see incredible benefit to onboarding these solutions and positively impact safety analysis at scale."